| Zeven (dalbavancin) / RaQualia, AbbVie |
NCT03426761: Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections |
|
|
| Completed | 4 | 41 | US | Dalbavancin, Dalvance, Xydalba, Zevan, Vancomycin, Daptomycin, Nafcillin, Cefazolin | Infectious Diseases Physicians, Inc., Johns Hopkins University | Bone Infection, Osteomyelitis, Septic Arthritis, Joint Infection, Prosthetic Joint Infection | 12/22 | 12/22 | | |
| Enrolling by invitation | 4 | 135 | US | Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, metronidazole, moxifloxacin, rifampin, trimethoprim-sulfamethoxazole, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem, meropenem, oritavancin, oxacillin, penicillin, piperacillin-tazobactam, tigecycline, vancomycin | West Virginia University | Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection, Pulmonary Infection, Gastrointestinal Infection, Genitourinary Infection | 08/24 | 08/24 | | |
| Recruiting | 4 | 100 | US | Long-Acting silver dressings, Aloe Vera, Dalbavancin | University of Colorado, Denver, Congressionally Directed Medical Research Programs | Frostbite | 05/26 | 08/26 | | |
| Withdrawn | 4 | 24 | NA | Dalbavancin, Dalvance | Wake Forest University Health Sciences | Gram-Positive Bacterial Infections, Soft Tissue Infections | 04/25 | 07/25 | | |
| Not yet recruiting | 3 | 406 | Europe | Dalbavancin, Powder for concentrate for solution for injection/infusion, Xydalba | CENTRE HOSPITALIER ANNECY GENEVOIS, French Ministery of Health (DGOS), ADVANZ Pharma | Staphylococcus aureus catheter bloodstream infection, Bloodstream infection caused by the bacterium Staphylococcus aureus in patients with a catheter and with a low risk for S. aureus associated complications, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
NCT02814916 / 2014-005281-30: Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA |
|
|
| Completed | 3 | 199 | Europe, US, RoW | Dalbavancin, Xydalba, Vancomycin, Oxacillin, Flucloxacillin, Cefadroxil, Clindamycin | AbbVie | Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections | 01/24 | 01/24 | | |
DALICATH, NCT05117398: Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus |
|
|
| Recruiting | 3 | 406 | Europe | Dalbavancin administration, Xydalba® administration, Standard antibiotic therapy, Standard documented antibiotic therapy | Assistance Publique - Hôpitaux de Paris, Centre Hospitalier de Perigueux, Advanz Pharma, CHU de Nantes, Centre National de Référence des staphylocoques | Catheter Bacteremia, Staphylococcus Aureus Infection | 09/25 | 09/26 | | |
SUDDEN-OUT, NCT04847921: Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition |
|
|
| Terminated | 2/3 | 11 | US | Dalbavancin, Dalvance | University of Colorado, Denver | Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia, Substance Use Disorders, Intravenous Substance Abuse | 10/23 | 10/23 | | |
2017-000934-77: Dalbavancin and Cefazolin as Antibiotic Prophylaxis in patients undergoing CABG Surgery Dalbavancin und Cefazolin als kontinuierliche Infusion zur antibiotischen Prophylaxe bei Patienten während einer koronararteriellen Bypass Operation |
|
|
| Ongoing | 2 | 16 | Europe | Powder for concentrate for solution for infusion, Powder for solution for injection/infusion, Xydalba 500mg, Cefazolin 2g | Medical University of Vienna, Department of Surgery, Division of Cardiac Surgery, AKH Wien, Herzchirurgie | Patients referred for CABG to the Department of Cardiac Surgery with planned isolated left mammary artery and vein/radial artery grafts preparation will be asked to participate in this trial. Patienten, die für die CABG an die Abteilung für Herzchirurgie überwiesen werden, werden gebeten, an dieser Studie teilzunehmen. Sie werden mit einer geplanten isolierten linken Brustarterie und Vene / Radialarterien-Transplantatpräparation versorgt., Deep sternal wound infections represents a severe complication after cardiac surgery. Patients undergoing CABG are at high for appalling postoperative infections. Tiefe Wundinfektionen stellen eine schwere Komplikation nach Herzoperationen dar. Patienten, die sich einer CABG unterziehen, sind bei entsetzlichen postoperativen Infektionen hoch., Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
2020-003169-20: Efficacy of dalbavancin during osteo-articular infections associated with hip and knee prostheses Efficacité de la dalbavancine au cours des infections ostéo-articulaires associées aux prothèses (IOAP) de hanche et de genou |
|
|
| Not yet recruiting | 2 | 43 | Europe | Powder for solution for infusion, XYDALBA | CHU de Nice, CHU de Nice | Osteo-articular infections Infections ostéo-articulaires associées aux prothèses, Osteo-articular infections Infections ostéo-articulaires associées aux prothèses, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT04775953: DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia |
|
|
| Completed | 2 | 200 | Canada, US | Cefazolin, Dalbavancin, Daptomycin, Nafcillin, Oxacillin, Vancomycin | National Institute of Allergy and Infectious Diseases (NIAID) | Staphylococcal Bacteraemia | 10/23 | 12/23 | | |
NCT03617042 / 2022-000415-32: Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection |
|
|
| Recruiting | 1 | 22 | US | Dalbavancin, Dalvance® | Allergan, Allergan | Bacterial Infections | 10/19 | 10/19 | | |
PRODALBA, NCT05046860: Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements |
|
|
| Recruiting | N/A | 43 | Europe | Dalbavancin | Centre Hospitalier Universitaire de Nice | Osteoarticular Infection | 09/24 | 09/24 | | |
DALBASAT, NCT06089044: Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections |
|
|
| Completed | N/A | 15 | Europe | Dalbavancin Injection | Tourcoing Hospital | Prosthesis-related Infections | 12/22 | 12/22 | | |
NCT04624451: Evaluation of Intravenous Dalbavancin for Peritonitis |
|
|
| Terminated | N/A | 2 | US | Dalbavancin | University of Colorado, Denver | Peritonitis, Peritonitis Bacterial | 12/23 | 01/24 | | |
